OSA Prevalence in Atrial Fibrillation Patients: Jordanian Study

Atrial Fibrillation Clinical Trial

Official title:

Prevalence of Obstructive Sleep Apnea Among Atrial Fibrillation Patients: A Cross-sectional Study From Jordan

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05990010
• Other study ID #: 22/130/2020
• Status: Completed
• Start date: February 2, 2020
• Est. completion date: July 25, 2023

Study information

• Verified date: October 2023
• Source: King Abdullah University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Current Knowledge:

Countless studies have been conducted to study the relationship between OSA and AF, and a significant association has been established between both diseases, owing to the numerous shared risk factors and a wide variety of pathophysiological changes resulting from both diseases being relevant to each other. Our study inspects this relationship from a cardiovascular standpoint, examining the prevalence of OSA in existing AF patients, which could be interpreted as AF being a risk factor for OSA development.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 545
• Est. completion date: July 25, 2023
• Est. primary completion date: July 25, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• Age 21 or above

Exclusion Criteria:

• Unable to give research consent

• Patients who were unwilling to complete the questionnaires

• Patients who suffer from mental illness

Related Conditions & MeSH terms

• Atrial Fibrillation
• Obstructive Sleep Apnea
• Sleep Apnea Syndromes
• Sleep Apnea, Obstructive

Intervention

Diagnostic Test:
• Berlin Questionnaire
The Berlin Questionnaire is a simple survey that helps doctors identify OSA risk. It looks at snoring, daytime sleepiness, obesity, and hypertension. A positive score in two or more areas indicates high risk, while one or none suggests low risk. It is an easy and effective tool to assess OSA risk, with proven validity.

Locations

Country	Name	City	State
Jordan	King Abdullah University Hospital cardiology clinics	Irbid	Ramtha

Sponsors (1)

Lead Sponsor	Collaborator
King Abdullah University Hospital

Country where clinical trial is conducted

Jordan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The Berlin Questionnaire survey	Prevalence of Obstructive Sleep Apnea among Atrial Fibrillation Patients	baseline